Trials / Completed
CompletedNCT01969617
Effects of Nalmefene After Single Dose on the Blood Oxygen Level Dependent (BOLD) fMRI Signal in the Ventral Striatum to Reward Responding in the Monetary Incentive Delay Task (MIDT), in Non-treatment Seeking Subjects With Alcohol Dependence Following Alcohol Challenge
Interventional, Randomized, Double-blind, Cross-over, Placebo-controlled Study to Investigate the Effects of Nalmefene After Single Dose on the Blood Oxygen Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Signal in the Ventral Striatum to Reward Responding in the Monetary Incentive Delay Task (MIDT), in Non-treatment Seeking Subjects With Alcohol Dependence Following Alcohol Challenge
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- Male
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To contribute to the understanding of the underlying neurobiological mechanism behind the interaction of alcohol and nalmefene
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nalmefene 18 mg, then placebo | One single oral dose Nalmefene on Day 1 and Placebo on Day 8 |
| DRUG | Placebo, then Nalmefene 18 mg | One single oral dose Placebo on Day 1 and Nalmefene on Day 8 |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2014-10-01
- First posted
- 2013-10-25
- Last updated
- 2014-11-11
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01969617. Inclusion in this directory is not an endorsement.